The Story of A14
Nanocare Technologies, Inc was founded in 2010 on the back of nearly 15 years of research and development by cofounder / CSO José Emilio (“Milo”) Fehr Pereira Lopes MD, PhD on an analog of methyl jasmonate as an anti-cancer therapeutic.
Nanocare is a preclinical stage
company focused on improving the
treatment of cancer.